Skip to main content
TipRanks
Go Ultimate75% OFF

ORIENTBIO, Inc. (002630) Stock Statistics & Valuation Metrics

Total Valuation

ORIENTBIO, Inc. has a market cap or net worth of KRW 35.76B. The enterprise value is KRW 68.05B.

Market Cap
KRW 35.76B
Enterprise Value
KRW 68.05B

Share Statistics

ORIENTBIO, Inc. has 29,645,752 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
29,645,752
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

ORIENTBIO, Inc.’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -5.74%.

Return on Equity (ROE)
-0.07
Return on Assets (ROA)
-0.06
Return on Invested Capital (ROIC)
-5.74%
Return on Capital Employed (ROCE)
-0.06
Revenue Per Employee
238.04M
Profits Per Employee
-36.54M
Employee Count
125
Asset Turnover
0.36
Inventory Turnover
10.59

Valuation Ratios

The current PE Ratio of ORIENTBIO, Inc. is 15.48. ORIENTBIO, Inc.’s PEG ratio is 0.06.

PE Ratio
15.48
PS Ratio
1.25
PB Ratio
0.50
Price to FCF
6.07
Price to Operating Cash Flow
5.04
PEG Ratio
0.06

Income Statement

In the last 12 months, ORIENTBIO, Inc. had revenue of 29.75B and earned -4.57B in profits. Earnings per share was -154.06.

Revenue
29.75B
Gross Profit
3.96B
Operating Income
-4.44B
Pretax Income
-4.57B
Net Income
-4.57B
EBITDA
-2.24B
Earnings Per Share (EPS)
-154.06

Cash Flow

In the last 12 months, operating cash flow was 7.09B and capital expenditures -1.20B, giving a free cash flow of 5.90B billion.

Operating Cash Flow
7.09B
Free Cash Flow
5.90B
Free Cash Flow per Share
198.87

Dividends & Yields

ORIENTBIO, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
16.48%
Earnings Yield
6.46%

Stock Price Statistics

Beta
-0.08
52-Week Price Change
-53.86%
50-Day Moving Average
1559.56
200-Day Moving Average
1924.97
Relative Strength Index (RSI)
37.93
Average Volume (3m)
72.10K

Important Dates

ORIENTBIO, Inc. upcoming earnings date is Feb 15, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Feb 15, 2027
Ex-Dividend Date
―

Financial Position

ORIENTBIO, Inc. as a current ratio of 7.82, with Debt / Equity ratio of 2.82%

Current Ratio
7.82
Quick Ratio
7.39
Debt to Market Cap
0.01
Net Debt to EBITDA
1.74
Interest Coverage Ratio
-34.60

Taxes

In the past 12 months, ORIENTBIO, Inc. has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

ORIENTBIO, Inc. EV to EBITDA ratio is 4.82, with an EV/FCF ratio of 4.41.

EV to Sales
0.91
EV to EBITDA
4.82
EV to Free Cash Flow
4.41
EV to Operating Cash Flow
3.67

Balance Sheet

ORIENTBIO, Inc. has KRW 38.08B in cash and marketable securities with KRW 1.19B in debt, giving a net cash position of KRW 36.89B billion.

Cash & Marketable Securities
KRW 38.08B
Total Debt
KRW 1.19B
Net Cash
KRW 36.89B
Net Cash Per Share
KRW 1,244.29
Tangible Book Value Per Share
KRW 2,435.12

Margins

Gross margin is 20.49%, with operating margin of 8.89%, and net profit margin of 8.07%.

Gross Margin
20.49%
Operating Margin
8.89%
Pretax Margin
8.07%
Net Profit Margin
8.07%
EBITDA Margin
18.82%
EBIT Margin
10.70%

Analyst Forecast

The average price target for ORIENTBIO, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-3.47%
EPS Growth Forecast
98.69%

Scores

Smart Score
―
AI Score
57